Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

[A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].

Takahashi T, Namiki K, Matsumoto H, Konno F, Mitsui K, Yoshida R.

Gan To Kagaku Ryoho. 2014 May;41(5):653-5. Japanese.

PMID:
24917016
[PubMed - indexed for MEDLINE]
2.

[A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].

Miyazawa T, Ebe K, Fujita N, Koide N, Honma K, Ikarashi T.

Gan To Kagaku Ryoho. 2012 Jun;39(6):1001-3. Japanese.

PMID:
22705702
[PubMed - indexed for MEDLINE]
3.

[A case report of pathologically complete response of rectal cancer after preoperative treatment of CPT-11, S-1, and radiation therapy].

Hamanaka M, Yamano T, Noda M, Tsukamoto K, Kuno T, Yamagishi D, Babaya A, Matsubara N, Kamikonya N, Tomita N.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2253-5. Japanese.

PMID:
22202346
[PubMed - indexed for MEDLINE]
4.

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.

Nogué M, Salud A, Vicente P, Arriví A, Roca JM, Losa F, Ponce J, Safont MJ, Guasch I, Moreno I, Ruiz A, Pericay C; AVACROSS Study Group.

Oncologist. 2011;16(5):614-20. doi: 10.1634/theoncologist.2010-0285. Epub 2011 Apr 5.

PMID:
21467148
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Neoadjuvant chemoradiotherapy for locally advanced rectal cancer].

Kuriu Y, Kokuba Y, Murayama Y, Komatsu S, Shiozaki A, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Ochiai T, Otsuji E.

Gan To Kagaku Ryoho. 2012 Nov;39(12):1951-3. Japanese.

PMID:
23267940
[PubMed - indexed for MEDLINE]
6.

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan.

Lee SU, Kim DY, Kim SY, Baek JY, Chang HJ, Kim MJ, Kim TH, Park JW, Oh JH.

Radiat Oncol. 2013 Nov 4;8:258. doi: 10.1186/1748-717X-8-258.

PMID:
24188746
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].

Ishida M, Miyazawa T, Ebe K, Koide N, Fujita N, Honma K, Ikarashi T.

Gan To Kagaku Ryoho. 2013 Jan;40(1):103-5. Japanese.

PMID:
23306929
[PubMed - indexed for MEDLINE]
8.

[Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].

Murata K, Okamura S, Okubo H, Owada Y, Nishigaki T, Wada Y, Kato R, Makino S, Takeoka T, Okada K, Fukuchi N, Ebisui C, Kinuta M.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2020-2. Japanese.

PMID:
24393999
[PubMed - indexed for MEDLINE]
9.

Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.

Hasegawa J, Nishimura J, Mizushima T, Miyake Y, Kim HM, Takemoto H, Tamagawa H, Noura S, Fujii M, Fujie Y, Kato T, Miwa H, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M.

Cancer Chemother Pharmacol. 2014 May;73(5):1079-87. doi: 10.1007/s00280-014-2417-9. Epub 2014 Mar 5.

PMID:
24595805
[PubMed - indexed for MEDLINE]
10.

Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.

Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1367-75. doi: 10.1016/j.ijrobp.2011.05.027. Epub 2011 Jul 19.

PMID:
21775070
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial.

Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH.

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):301-5. doi: 10.1016/j.ijrobp.2013.10.034. Epub 2013 Dec 5.

PMID:
24315563
[PubMed - indexed for MEDLINE]
12.

Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.

Landry JC, Feng Y, Cohen SJ, Staley CA 3rd, Whittington R, Sigurdson ER, Nimeiri H, Verma U, Prabhu RS, Benson AB.

Cancer. 2013 Apr 15;119(8):1521-7. doi: 10.1002/cncr.27890. Epub 2013 Jan 3.

PMID:
23288663
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[A long-term survival case of rectal cancer with Virchow's lymph node metastasis by multimodality therapy].

Hirose H, Ikeda M, Miyoshi N, Kim HM, Okano M, Uemura M, Yamashita S, Takemasa I, Mizushima T, Yamamoto H, Ishii H, Sekimoto M, Doki Y, Mori M.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2545-7. Japanese.

PMID:
21224634
[PubMed - indexed for MEDLINE]
14.

Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: a phase II trial.

Kennecke H, Berry S, Wong R, Zhou C, Tankel K, Easaw J, Rao S, Post J, Hay J.

Eur J Cancer. 2012 Jan;48(1):37-45. doi: 10.1016/j.ejca.2011.05.016. Epub 2011 Jun 12.

PMID:
21664123
[PubMed - indexed for MEDLINE]
15.

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.

Velenik V, Ocvirk J, Music M, Bracko M, Anderluh F, Oblak I, Edhemovic I, Brecelj E, Kropivnik M, Omejc M.

Radiat Oncol. 2011 Aug 31;6:105. doi: 10.1186/1748-717X-6-105.

PMID:
21880132
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Analysis of bevacizumab-based preoperative radiochemotherapy in patients with locally advanced rectal cancer on surgery-associated spectrum of complications.

Dellas K, Buller J, Görtz GJ, Richter M, Höhler T, Arnold D, Keck T, Dunst J, Zühlke H.

Ann Surg Oncol. 2014 Apr;21(4):1352-60. doi: 10.1245/s10434-013-3412-9. Epub 2013 Dec 4.

PMID:
24306667
[PubMed - indexed for MEDLINE]
17.

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.

Chiorean EG, Sanghani S, Schiel MA, Yu M, Burns M, Tong Y, Hinkle DT, Coleman N, Robb B, LeBlanc J, Clark R, Bufill J, Curie C, Loehrer PJ, Cardenes H.

Cancer Chemother Pharmacol. 2012 Jul;70(1):25-32. doi: 10.1007/s00280-012-1883-1. Epub 2012 May 18.

PMID:
22610353
[PubMed - indexed for MEDLINE]
18.

[Neoadjuvant chemotherapy with combination of S-1 and CPT-11 in advanced rectal cancer - a case report].

Murakami H, Yamakawa M, Han I, Hatori S, Suzuki M, Iwasaki H, Takanashi Y.

Gan To Kagaku Ryoho. 2007 Oct;34(10):1667-9. Japanese.

PMID:
17940387
[PubMed - indexed for MEDLINE]
19.

Neoadjuvant chemoradiation therapy using concurrent S-1 and irinotecan in rectal cancer: impact on long-term clinical outcomes and prognostic factors.

Nakamura T, Yamashita K, Sato T, Ema A, Naito M, Watanabe M.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):547-55. doi: 10.1016/j.ijrobp.2014.03.007.

PMID:
24929164
[PubMed - indexed for MEDLINE]
20.

[A case of metastatic colon cancer effectively treated by XELOX and IRIS].

Nishizawa T, Kinoshita S, Sakuno T, Fujiyama Y, Kikuchi M, Kaneko H, Suzuki H, Takahashi M.

Gan To Kagaku Ryoho. 2013 Jun;40(6):807-9. Japanese.

PMID:
23863664
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk